This compares favorably to Semaglutide (44% nausea rate) despite Retatrutide producing superior weight loss
Results showed dose-dependent weight loss reaching 22.5% at the highest dose over 72 weeks
Citations Citations to this article as recorded by Regulation of immune tolerance in hepatocellular carcinoma by liver diseases: a review Jinyi Li, Yuanda Liu Infectious Agents and Cancer .2026;[Epub] CrossRef 3,092 View 357 Download Crossref Review Hepatic neoplasm Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment Soo Young Hwang, Pojsakorn Danpanichkul, Vatche Agopian, Neil Mehta, Neehar D
They work faster and ensure higher absorption
RISKS FOR HEALTHCARE PROVIDERS CREATED BY GLP-1S Even as its getting easier for patients to obtain GLP-1s, there is still a relatively small number of healthcare providers trained in obesity care